IP Library Granted Patent US 8,809,259
Granted Patent B2
US 8,809,259 · App. 13/836,855 · Granted Aug 19, 2014

Charged nutritive proteins and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,259
App. No.
13/836,855
Granted
Aug 19, 2014
Kind
B2
Abstract

Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 50 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 100 g/L at pH 7. In some embodiments the nutritive proteins comprise at least one of a level of a) a ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of branch chain amino acid residues to total amino acid residues present in a benchmark protein; b) a ratio of leucine residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of leucine residues to total amino acid residues present in a benchmark protein; and c) a ratio of essential amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of essential amino acid residues to total amino acid residues present in a benchmark protein. Also provided are nucleic acids encoding the proteins, recombinant microorganisms that make the proteins, methods of making the proteins using recombinant microorganisms, compositions that comprise the proteins, and methods of using the proteins, among other things.

Claims (27)

1. A nutritive composition comprising an isolated nutritive protein comprising a first polypeptide sequence, wherein the nutritive protein comprises an aqueous solubility of at least 50 g/l at pH7 and a stimulated gastric digestion half-life of less than 10 minutes, and wherein the first polypeptide sequence comprises:

a. a ratio of Leu residues to total amino acids residues of at least 6%;

b. a ratio of essential amino acid residues to total amino acid residues of at least 34%;

c. a ratio of branch chain amino acid residues to total amino acid residues of at least 18%; and

d. 0, 1, 2, or 3 cysteine residues.

2. The isolated nutritive protein of claim 1 , wherein the nutritive protein has an aqueous solubility of at least 100 g/L at pH 7.

3. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence comprises:

a. a ratio of branch chain amino acid residues to total amino acid residues of at least 20%;

b. a ratio of Leu residues to total amino acid residues of at least 11%; and

c. a ratio of essential amino acid residues to total amino acid residues of at least 44%.

4. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence further comprises at least one of each essential amino acid.

5. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence comprises:

a. a ratio of branch chain amino acid residues to total amino acid residues of at least 23%;

b. a ratio of Leu residues to total amino acid residues of at least 13%; and

c. a ratio of essential amino acid residues to total amino acid residues of at least 44%.

6. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence has less than 50% global homology to a known allergen.

7. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence has less than 50% global homology to a known toxin.

8. The isolated nutritive protein of claim 1 , wherein the nutritive protein has a simulated gastric digestion half-life of less than 2 minutes.

9. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence has 0 cysteine residues.

10. The isolated nutritive protein of claim 1 , wherein the polypeptide sequence, when present at a concentration of 12.5 mg/mL, does not form insoluble aggregates in aqueous solution at 95° C.

11. The isolated nutritive protein of claim 1 , wherein the isolated nutritive protein further comprises a polypeptide tag for affinity purification.

12. The nutritive composition of claim 1 , further comprising at least one second component selected from a protein, a polypeptide, a peptide, a free amino acid, a carbohydrate, a lipid, a mineral or mineral source, a vitamin, a supplement, an organism, a pharmaceutical, and an excipient.

13. The nutritive composition of claim 1 , wherein the nutritive composition is formulated as a liquid solution, slurry, suspension, gel, paste, powder, or solid.

14. The nutritive composition of claim 1 , wherein the nutritive protein is at least 90% pure relative to total protein.

15. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence is at least 20, 50, or 100 amino acids in length.

16. The isolated nutritive protein of claim 1 , wherein the first polypeptide sequence does not comprise N-linked glycosylation, O-linked glycosylation, or both N-linked and O-linked glycosylation.

17. The nutritive composition of claim 12 , further comprising calcium.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: AXCELLA HEALTH INC.
To: AXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 066125/0228 →
RELEASE OF SECURITY INTEREST Recorded Dec 15, 2022
From: SLR INVESTMENT CORP.
To: AXCELLA HEALTH INC.
Reel/Frame 062137/0569 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Sep 2, 2021
From: AXCELLA HEALTH INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 057435/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2016
From: PRONUTRIA BIOSCIENCES, INC.
To: AXCELLA HEALTH INC.
Reel/Frame 040249/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2016
From: PRONUTRIA, INC.
To: PRONUTRIA BIOSCIENCES, INC.
Reel/Frame 038177/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: KRAMARCZYK, JOHN F.
To: PRONUTRIA, INC.
Reel/Frame 033087/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2013
From: BERRY, DAVID ARTHUR; BOGHIGIAN, BRETT ADAM; SILVER, NATHANIEL W.; VON MALTZAHN, GEOFFREY; CHILLAKURU, RAJEEV; HAMILL, MIKE
To: PRONUTRIA, INC.
Reel/Frame 030992/0482 →